116 related articles for article (PubMed ID: 38462898)
1. The association of metabolic syndrome score trajectory patterns with risk of all cancer types.
Deng L; Liu T; Liu CA; Zhang Q; Song MM; Lin SQ; Wang YM; Zhang QS; Shi HP
Cancer; 2024 Jun; 130(12):2150-2159. PubMed ID: 38462898
[TBL] [Abstract][Full Text] [Related]
2. Dose-response relationship between distinct serum uric acid trajectories and metabolic syndrome risk: A 5-year prospective cohort study.
Zhang S; Ma Z; Li Q; Liu J; Tao L; Han Y; Zhang J; Guo X; Yang X
Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1189-1199. PubMed ID: 33549428
[TBL] [Abstract][Full Text] [Related]
3. Association between metabolic syndrome, C-reactive protein, and the risk of primary liver cancer: a large prospective study.
Song M; Liu T; Liu H; Zhang Q; Zhang Q; Wang Y; Ma X; Cao L; Shi H
BMC Cancer; 2022 Aug; 22(1):853. PubMed ID: 35927639
[TBL] [Abstract][Full Text] [Related]
4. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III.
Gathirua-Mwangi WG; Song Y; Monahan PO; Champion VL; Zollinger TW
Int J Cancer; 2018 Aug; 143(3):535-542. PubMed ID: 29488212
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein trajectories and the risk of all cancer types: A prospective cohort study.
Liu T; Zhang Q; Song C; Siyin ST; Chen S; Zhang Q; Song M; Cao L; Shi H
Int J Cancer; 2022 Jul; 151(2):297-307. PubMed ID: 35368093
[TBL] [Abstract][Full Text] [Related]
6. Association between metabolic syndrome and kidney cancer risk: a prospective cohort study.
Wang L; Du H; Sheng C; Dai H; Chen K
Lipids Health Dis; 2024 May; 23(1):142. PubMed ID: 38760801
[TBL] [Abstract][Full Text] [Related]
7. Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study.
Tran TT; Gunathilake M; Lee J; Kim J
Cancer; 2022 Mar; 128(6):1230-1241. PubMed ID: 34762301
[TBL] [Abstract][Full Text] [Related]
8. Proinflammatory Dietary Intake is Associated with Increased Risk of Metabolic Syndrome and Its Components: Results from the Population-Based Prospective Study.
Khan I; Kwon M; Shivappa N; R Hébert J; Kim MK
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32344617
[TBL] [Abstract][Full Text] [Related]
9. Impact of the baseline insulin resistance surrogates and their longitudinal trajectories on cardiovascular disease (coronary heart disease and stroke): a prospective cohort study in rural China.
Wang S; Zhang X; Keerman M; Guo H; He J; Maimaitijiang R; Wang X; Ma R; Guo S
Front Endocrinol (Lausanne); 2023; 14():1259062. PubMed ID: 38189050
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome and risk of pancreatic cancer: A population-based prospective cohort study.
Xia B; He Q; Pan Y; Gao F; Liu A; Tang Y; Chong C; Teoh AYB; Li F; He Y; Zhang C; Yuan J
Int J Cancer; 2020 Dec; 147(12):3384-3393. PubMed ID: 32580250
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome increases osteoarthritis risk: findings from the UK Biobank prospective cohort study.
Zhang S; Wang D; Zhao J; Zhao H; Xie P; Zheng L; Sheng P; Yuan J; Xia B; Wei F; Zhang Z
BMC Public Health; 2024 Jan; 24(1):233. PubMed ID: 38243159
[TBL] [Abstract][Full Text] [Related]
12. Association between metabolic syndrome and the risk of colorectal cancer: a prospective study in China.
Wang Z; Chen R; Zhang L; Chen Y; Li J; Li S; Xu L; Hu Y; Bai Y
Eur J Cancer Prev; 2024 Jul; 33(4):347-354. PubMed ID: 38375832
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and rare gynecological cancers in the metabolic syndrome and cancer project (Me-Can).
Nagel G; Concin H; Bjørge T; Rapp K; Manjer J; Hallmans G; Diem G; Häggström C; Engeland A; Almquist M; Jonsson H; Selmer R; Stocks T; Tretli S; Ulmer H; Stattin P; Lukanova A
Ann Oncol; 2011 Jun; 22(6):1339-1345. PubMed ID: 20966183
[TBL] [Abstract][Full Text] [Related]
14. The combination of metabolic syndrome and inflammation increased the risk of colorectal cancer.
Liu T; Fan Y; Zhang Q; Wang Y; Yao N; Song M; Zhang Q; Cao L; Song C; Shi H
Inflamm Res; 2022 Aug; 71(7-8):899-909. PubMed ID: 35715516
[TBL] [Abstract][Full Text] [Related]
15. Association of metabolic syndrome and its components with the risk of urologic cancers: a prospective cohort study.
Jiang R; Wang X; Li Z; Cai H; Sun Z; Wu S; Chen S; Hu H
BMC Urol; 2023 Sep; 23(1):150. PubMed ID: 37736725
[TBL] [Abstract][Full Text] [Related]
16. The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study.
Ding C; Yang Z; Wang S; Sun F; Zhan S
Endocrine; 2018 May; 60(2):282-291. PubMed ID: 29492904
[TBL] [Abstract][Full Text] [Related]
17. The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?
Harding J; Sooriyakumaran M; Anstey KJ; Adams R; Balkau B; Briffa T; Davis TM; Davis WA; Dobson A; Giles GG; Grant J; Knuiman M; Luszcz M; Mitchell P; Pasco JA; Reid C; Simmons D; Simons L; Tonkin A; Woodward M; Shaw JE; Magliano DJ
Diabetes Metab; 2015 Dec; 41(6):463-9. PubMed ID: 26037090
[TBL] [Abstract][Full Text] [Related]
18. The association between fasting blood glucose trajectory and cancer risk in Chinese population without diabetes.
Feng X; Wang G; Lyu Z; Chen S; Wei L; Li X; Wen Y; Chen Y; Xie S; Cui H; Chen H; Li J; Lin C; Ren J; Shi J; Wu S; Dai M; Li N; He J
Int J Cancer; 2020 Aug; 147(4):958-966. PubMed ID: 31900925
[TBL] [Abstract][Full Text] [Related]
19. Favorable Dietary Patterns Associated with Lower Incidence of Metabolic Syndrome in Middle-Aged Japanese Men: A Prospective Cohort Study.
Taniguchi H; Kobayashi Y; Shima T; Ueda M; Wada S
J Nutr Sci Vitaminol (Tokyo); 2023; 69(4):251-258. PubMed ID: 37648511
[TBL] [Abstract][Full Text] [Related]
20. Trajectory patterns of metabolic syndrome severity score and risk of type 2 diabetes.
Amouzegar A; Honarvar M; Masoumi S; Khalili D; Azizi F; Mehran L
J Transl Med; 2023 Oct; 21(1):750. PubMed ID: 37880756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
